Key Metrics
CiteScore 

4.5
Impact Factor 

< 5
SJR 

Q3Biological Psychiatry

SNIP 

1.09
Recommended pre-submission checks
Powered by 

Topics Covered on Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Neuropsychiatric Disease and Treatment ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Neuropsychiatric Disease and Treatment
Cistanche deserticola Stem Extract Attenuates Depression Through NF-\u03baB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation
- 13 May 2026
- Neuropsychiatric Disease and Treatment
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Na\xefve First-Episode Schizophrenia
- 13 May 2026
- Neuropsychiatric Disease and Treatment
Functional Impairment and Post-Stroke Depression: Potential Roles of Sleep Quality and Fatigue in a Cross-Sectional Structural Equation Analysis
- 12 May 2026
- Neuropsychiatric Disease and Treatment
Psychomotor Rehabilitation for Pediatric Delirium: A Study Protocol for a Randomized Controlled Trial Investigating Efficacy and Brain Electrophysiological Mechanisms
- 11 May 2026
- Neuropsychiatric Disease and Treatment
Role of Electroencephalographic Biomarkers as Predictors of Post-Stroke Cognitive Outcomes in Patients with Cerebral Infarction: Literature Review
- 11 May 2026
- Neuropsychiatric Disease and Treatment
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
- 8 May 2026
- Neuropsychiatric Disease and Treatment
Cistanche deserticola Stem Extract Attenuates Depression Through NF-\u03baB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation
- 13 May 2026
- Neuropsychiatric Disease and Treatment
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Na\xefve First-Episode Schizophrenia
- 13 May 2026
- Neuropsychiatric Disease and Treatment
Functional Impairment and Post-Stroke Depression: Potential Roles of Sleep Quality and Fatigue in a Cross-Sectional Structural Equation Analysis
- 12 May 2026
- Neuropsychiatric Disease and Treatment
Psychomotor Rehabilitation for Pediatric Delirium: A Study Protocol for a Randomized Controlled Trial Investigating Efficacy and Brain Electrophysiological Mechanisms
- 11 May 2026
- Neuropsychiatric Disease and Treatment
Role of Electroencephalographic Biomarkers as Predictors of Post-Stroke Cognitive Outcomes in Patients with Cerebral Infarction: Literature Review
- 11 May 2026
- Neuropsychiatric Disease and Treatment
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
- 8 May 2026
- Neuropsychiatric Disease and Treatment